These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22939842)

  • 21. Vitamin D and testosterone co-ordinately modulate intracellular zinc levels and energy metabolism in prostate cancer cells.
    Zhang P; Schatz A; Adeyemi B; Kozminski D; Welsh J; Tenniswood M; Wang WW
    J Steroid Biochem Mol Biol; 2019 May; 189():248-258. PubMed ID: 30664926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of cellular phosphorylation state affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells.
    Hara H; Yasunami Y; Adachi T
    Biochem Biophys Res Commun; 2002 Aug; 296(1):182-8. PubMed ID: 12147248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.
    Kaeding J; Bélanger J; Caron P; Verreault M; Bélanger A; Barbier O
    Mol Cancer Ther; 2008 Feb; 7(2):380-90. PubMed ID: 18281521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
    Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
    Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Br J Cancer; 2003 Mar; 88(6):928-32. PubMed ID: 12644831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variations in the vitamin D receptor, androgen receptor and enzymes that regulate androgen metabolism.
    Price DK; Franks ME; Figg WD
    J Urol; 2004 Feb; 171(2 Pt 2):S45-9; discussion S49. PubMed ID: 14713753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cells.
    Chae YJ; Cho KH; Yoon IS; Noh CK; Lee HJ; Park Y; Ji E; Seo MD; Maeng HJ
    Planta Med; 2016 Jan; 82(1-2):121-30. PubMed ID: 26366751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway.
    Wang K; Chen S; Xie W; Wan YJ
    Biochem Pharmacol; 2008 Jun; 75(11):2204-13. PubMed ID: 18400206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1alpha,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer.
    Fan J; Liu S; Du Y; Morrison J; Shipman R; Pang KS
    J Pharmacol Exp Ther; 2009 Aug; 330(2):389-402. PubMed ID: 19414624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.
    Solomon JD; Heitzer MD; Liu TT; Beumer JH; Parise RA; Normolle DP; Leach DA; Buchanan G; DeFranco DB
    Mol Cancer Res; 2014 Aug; 12(8):1166-80. PubMed ID: 24825850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
    Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF
    Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
    Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
    J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31.
    Hedlund TE; Moffatt KA; Miller GJ
    J Steroid Biochem Mol Biol; 1996 Jun; 58(3):277-88. PubMed ID: 8836163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation.
    Comeglio P; Chavalmane AK; Fibbi B; Filippi S; Marchetta M; Marini M; Morelli A; Penna G; Vignozzi L; Vannelli GB; Adorini L; Maggi M
    J Endocrinol Invest; 2010 Nov; 33(10):730-8. PubMed ID: 20386089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D in Prostate Cancer.
    Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
    Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.
    Malloy PJ; Peng L; Wang J; Feldman D
    Endocrinology; 2009 Apr; 150(4):1580-7. PubMed ID: 19056816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulating CYP3A4 expression in C3A cells by transfection with a novel chimeric regulator of hPXR-p53-AD.
    Chen F; Rao XH; Yang JL; Pan MX; Gao Y; Li ZL; Li Y; Zhu YF; Wang Y
    PLoS One; 2014; 9(5):e95752. PubMed ID: 24788541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.
    Singh PK; Doig CL; Dhiman VK; Turner BM; Smiraglia DJ; Campbell MJ
    J Steroid Biochem Mol Biol; 2013 Jul; 136():258-63. PubMed ID: 23098689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin regulation of CYP3A4 and CYP3A5 expression.
    Willrich MA; Hirata MH; Hirata RD
    Pharmacogenomics; 2009 Jun; 10(6):1017-24. PubMed ID: 19530969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.